ArticleCureus2026
Prevalence of Mild Autonomous Cortisol Secretion Among Patients With Adrenal Incidentaloma and Its Association With Metabolic Abnormalities: A Hospital-Based, Analytical, Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Mild autonomous cortisol secretion (MACS) is a common hormonal abnormality among patients with adrenal incidentaloma and has been associated with cardiometabolic abnormalities. However, evidence regarding its prevalence and metabolic associations in Pakistani populations remains limited. This study aimed to determine the prevalence of MACS among patients with adrenal incidentaloma and evaluate its association with metabolic abnormalities. Methodology A hospital-based, analytical, cross-sectional study was conducted among 380 adults with adrenal incidentaloma at Jinnah Hospital, Lahore, affiliated with Allama Iqbal Medical College, Pakistan. Participants underwent clinical, anthropometric, biochemical, hormonal, and radiological assessment. MACS was evaluated using the 1-mg overnight dexamethasone suppression test, with assessment of morning adrenocorticotropic hormone (ACTH) and dehydroepiandrosterone sulfate to support ACTH-independent cortisol secretion. Metabolic abnormalities, including obesity, central obesity, hypertension, diabetes mellitus, dyslipidemia, and metabolic syndrome, were assessed. Multivariable logistic regression was performed to evaluate independent associations after adjustment for relevant demographic, lifestyle, clinical, medication-related, and radiological covariates. Results MACS was identified in 95 (25.0%) participants. Compared with patients without MACS, those with MACS had higher frequencies of obesity, central obesity, hypertension, diabetes mellitus, dyslipidemia, and metabolic syndrome, as well as a greater burden of multiple metabolic abnormalities. After multivariable adjustment, MACS was independently associated with obesity (adjusted odds ratio (aOR) = 1.85, 95% confidence interval (CI) = 1.09-3.14; p = 0.022), diabetes mellitus (aOR = 1.68, 95% CI = 1.01-2.80; p = 0.046), metabolic syndrome (aOR = 1.82, 95% CI = 1.11-2.98; p = 0.017), and the presence of ≥2 metabolic abnormalities (aOR = 1.92, 95% CI = 1.17-3.15; p = 0.010). Larger adrenal lesion size was independently associated with MACS (aOR = 1.38 per cm, 95% CI = 1.14-1.67; p = 0.001). Conclusions MACS was present in one-quarter of patients with adrenal incidentaloma and was associated with a greater cardiometabolic burden. These findings highlight the potential importance of assessing cortisol secretion and metabolic risk in patients with adrenal incidentaloma, while prospective multicenter studies are needed to clarify the clinical significance and temporal relationships of these associations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.